• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Studies of the kallikrein-kinin system in patients with sickle cell anemia.镰状细胞贫血患者激肽释放酶-激肽系统的研究。
J Natl Med Assoc. 1983 Jun;75(6):551-6.
2
Reduced plasma kininogen concentration during sickle cell crisis.镰状细胞危象期间血浆激肽原浓度降低。
Res Commun Chem Pathol Pharmacol. 1983 Aug;41(2):313-22.
3
Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin.凝血因子XII及前激肽释放酶-激肽释放酶-激肽在人血浆肾素原冷激活中的作用
Clin Sci (Lond). 1984 May;66(5):533-9. doi: 10.1042/cs0660533.
4
The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.巴特综合征中的激肽释放酶-激肽系统及其对前列腺素合成酶抑制的反应。
J Clin Invest. 1978 Jun;61(6):1671-82. doi: 10.1172/JCI109088.
5
Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.振动对大鼠血浆激肽释放酶-激肽系统活性的影响。
Acta Physiol Acad Sci Hung. 1982;60(4):213-8.
6
Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.对正常个体和脓毒性休克患者血浆样本中血浆激肽释放酶-激肽系统成分的研究。
Adv Shock Res. 1980;4:1-10.
7
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.遗传性血管性水肿中的前激肽释放酶激活和高分子量激肽原消耗
N Engl J Med. 1983 May 5;308(18):1050-3. doi: 10.1056/NEJM198305053081802.
8
Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.源自因子XII的活性片段的降压作用是由血浆激肽释放酶-激肽系统的激活介导的。
Circ Shock. 1988 Dec;26(4):375-82.
9
Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.由于凝血因子XII基因突变Thr309Lys导致的遗传性血管性水肿中的激肽释放酶-激肽系统与纤维蛋白溶解
Blood Coagul Fibrinolysis. 2009 Jul;20(5):325-32. doi: 10.1097/MBC.0b013e32832811f8.
10
[Proteases which relate to kallikrein-kinin system and blood coagulation system (author's transl)].与激肽释放酶-激肽系统和血液凝固系统相关的蛋白酶(作者译)
Tanpakushitsu Kakusan Koso. 1980;25(6):547-60.

引用本文的文献

1
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.因子 XII 有助于镰状细胞病中的血栓并发症和血管闭塞。
Blood. 2023 Apr 13;141(15):1871-1883. doi: 10.1182/blood.2022017074.
2
Linking Labile Heme with Thrombosis.将不稳定血红素与血栓形成联系起来。
J Clin Med. 2021 Jan 22;10(3):427. doi: 10.3390/jcm10030427.
3
Therapeutic strategies for sickle cell disease: towards a multi-agent approach.镰状细胞病的治疗策略:迈向多药物联合治疗方法。
Nat Rev Drug Discov. 2019 Feb;18(2):139-158. doi: 10.1038/s41573-018-0003-2.
4
How I diagnose and treat venous thromboembolism in sickle cell disease.如何在镰状细胞病中诊断和治疗静脉血栓栓塞症。
Blood. 2018 Oct 25;132(17):1761-1769. doi: 10.1182/blood-2018-03-822593. Epub 2018 May 15.
5
Sickle cell disease: an inherited thrombophilia.镰状细胞病:一种遗传性血栓形成倾向。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):640-647. doi: 10.1182/asheducation-2016.1.640.
6
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.镰状细胞病的凝血异常:与临床结局的关系及疾病修饰疗法的影响。
Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24.
7
Inhibition of plasma kallikrein by a highly specific active site blocking antibody.一种高度特异性的活性位点阻断抗体对血浆激肽释放酶的抑制作用。
J Biol Chem. 2014 Aug 22;289(34):23596-608. doi: 10.1074/jbc.M114.569061. Epub 2014 Jun 26.
8
Red blood cells and thrombin generation in sickle cell disease.镰状细胞病中的红细胞和凝血酶生成。
Thromb Res. 2014 May;133 Suppl 1(0 1):S52-3. doi: 10.1016/j.thromres.2014.03.021.
9
Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.止血系统在镰状细胞病病理生理学及潜在治疗方法中的作用。
Hematol Oncol Clin North Am. 2014 Apr;28(2):355-74. doi: 10.1016/j.hoc.2013.11.011. Epub 2014 Jan 18.

本文引用的文献

1
The liver in sickle cell disease. A clinicopathologic study of 70 patients.镰状细胞病中的肝脏。70例患者的临床病理研究。
Am J Med. 1980 Dec;69(6):833-7. doi: 10.1016/s0002-9343(80)80008-8.
2
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.人血浆中的激肽原-激肽酶系统。成分测定及疾病状态观察。
Ann Intern Med. 1969 Oct;71(4):763-73. doi: 10.7326/0003-4819-71-4-763.
3
A radioimmunoassay for bradykinin in plasma and synovial fluid.血浆和滑液中缓激肽的放射免疫测定法。
J Lab Clin Med. 1969 Nov;74(5):816-27.
4
Role of coagulation system in pathophysiology of sickle cell disease.凝血系统在镰状细胞病病理生理学中的作用。
Arch Intern Med. 1974 Apr;133(4):635-41.
5
Kallikrein-bradykinin system in chronic alcoholic liver disease.慢性酒精性肝病中的激肽释放酶-缓激肽系统
Ann Intern Med. 1972 Aug;77(2):205-9. doi: 10.7326/0003-4819-77-2-205.
6
Hemostatic alterations accompanying sickle cell pain crises.镰状细胞疼痛危象伴随的止血改变。
J Lab Clin Med. 1976 Sep;88(3):440-9.
7
Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.表面结合的Hageman因子的激活:高分子量激肽原的卓越作用及一种新因子的证据
Adv Exp Med Biol. 1976;70(00):285-99. doi: 10.1007/978-1-4684-3267-1_35.
8
Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.人类血浆前激肽释放酶(弗莱彻因子)在健康与疾病状态下的凝血活性及抗原水平。
J Lab Clin Med. 1978 Jul;92(1):84-95.
9
Serum protein profile in sickle cell disease.镰状细胞病的血清蛋白谱
J Clin Pathol. 1979 Feb;32(2):117-21. doi: 10.1136/jcp.32.2.117.
10
Serial changes in coagulation and viscosity during sickle-cell crisis.镰状细胞危象期间凝血和粘度的系列变化。
Br J Haematol. 1979 Jan;41(1):95-103. doi: 10.1111/j.1365-2141.1979.tb03685.x.

镰状细胞贫血患者激肽释放酶-激肽系统的研究。

Studies of the kallikrein-kinin system in patients with sickle cell anemia.

作者信息

Miller R L, Verma P S, Adams R G

出版信息

J Natl Med Assoc. 1983 Jun;75(6):551-6.

PMID:6603519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2561580/
Abstract

Eight patients with sickle cell anemia (SS hemoglobin) were found to have decreased plasma levels of prekallikrein compared to normal control subjects or patients with other types of anemia. The prekallikrein levels in the patients with sickle cell anemia were found to decrease further during a sickle cell crisis. These results suggest that components of the kallikrein-kinin system are profoundly affected in patients with sickle cell anemia, and during crises may play a role in the clinical presentation of patients.

摘要

与正常对照受试者或其他类型贫血患者相比,发现8例镰状细胞贫血(SS血红蛋白)患者的血浆前激肽释放酶水平降低。镰状细胞贫血患者的前激肽释放酶水平在镰状细胞危象期间进一步下降。这些结果表明,激肽释放酶-激肽系统的成分在镰状细胞贫血患者中受到严重影响,并且在危象期间可能在患者的临床表现中起作用。